LYKOS THERAPEUTICS

MAPS Public Benefit Corporation

Application Filed: 2024-01-04

Trademark Application Details

Status

630

Live/Pending

NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER

Research	OneLook Acronym Finder
Serial Number	98341180
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Karen Won
Attorney Docket Number	061786-400

Timeline

2024-01-04	Application Filed
2024-01-04	Status: Live/Pending
2024-01-04	Transaction Date

Trademark Applicants & Owners

Owner:	MAPS Public Benefit Corporation
Address	350 Lincoln Street, Suite 1103 Hingham DE 02043
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Karen Won
Mintz, Levin, Cohn, Ferris, Glovsky, and
One Financial Center
Boston,MA 02111

Good, Services, and Codes

International Codes:	5
U.S. Codes:	052,051,005,018,006,044,046
International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0051	Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.

Type Code

Type

GS0051

Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED	2024-01-04	1 NWAP I:Incoming Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2024-04-03	2 ASGN I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	2024-04-21	3 NWOS I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.